Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
WSWest Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. (WST)

New York Stock Exchange · Currency in USD
$392.15 ▼ -1.88 (-0.48%)
At close: Oct 23, 4:00 PM ET. Market closed.
$392.15 ▲ +0.00 (+0.00%)
After hours: Oct 23, 4:05 PM ET

Summary

Previous Close
$394.03
Open
$391.60
Day's Range
$389.72 – $394.18
52 Week Range
$223.83 – $397.16
Volume
718,047
Avg. Volume
656,512
Market Cap
$27.60B
Beta (5Y Monthly)
1.13
PE Ratio (TTM)
49.83
EPS (TTM)
$7.98
Earnings Date
Oct 29, 2026
Forward Dividend & Yield
$1.04 (0.27%)
Ex-Dividend Date
Nov 10, 2026
1y Target Est
$419.50

Profile: West Pharmaceutical Services, Inc.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
10,800
CEO
Michel Lagarde

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements.

Earnings

Next report: Thu, Oct 29, 2026
EPS estimate $2.20 · Revenue est. $827.12M
DateEst.Actual
Jul 23, 2026$2.08$2.37Beat
Apr 23, 2026$1.68$2.13Beat
Feb 12, 2026$1.83$2.04Beat
Oct 23, 2025$1.68$1.96Beat
Jul 24, 2025$1.51$1.84Beat
Apr 24, 2025$1.22$1.45Beat

Analyst view

Consensus price target
$419.50 ▲ +7.0%
Range $390.00 – $447.00
Rating: Buy
Buy 82% · Hold 12% · Sell 6%

Get free alerts on WST and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.